<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Toolchain-Strategy on CuraDevOps</title><link>https://curadevops.metacog.co.kr/tags/toolchain-strategy/</link><description>Recent content in Toolchain-Strategy on CuraDevOps</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 08 Oct 2026 17:40:34 +0000</lastBuildDate><atom:link href="https://curadevops.metacog.co.kr/tags/toolchain-strategy/index.xml" rel="self" type="application/rss+xml"/><item><title>HashiCorp signals future direction for Terraform CDK (CDKTF)</title><link>https://curadevops.metacog.co.kr/insights/2026-10-08-the-future-of-terraform-cdk/</link><pubDate>Thu, 08 Oct 2026 17:40:34 +0000</pubDate><guid>https://curadevops.metacog.co.kr/insights/2026-10-08-the-future-of-terraform-cdk/</guid><description>&lt;ul>
&lt;li>&lt;strong>Platform/SRE — Plan:&lt;/strong> If your team uses CDKTF for infrastructure, this HN discussion signals potential direction changes worth tracking; no concrete EOL date means no Act, but evaluate whether to continue investing in CDKTF vs. native HCL or OpenTofu-based workflows this quarter.&lt;/li>
&lt;li>&lt;strong>CI/CD — Skip&lt;/strong>&lt;/li>
&lt;li>&lt;strong>Leader — Plan:&lt;/strong> A high-signal HN thread (136 pts, 134 comments) on CDKTF&amp;rsquo;s future warrants a toolchain-risk review if your org has standardized on it — especially given the HashiCorp/IBM acquisition context; assess alternatives before teams invest further.&lt;/li>
&lt;/ul></description></item></channel></rss>